Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas

Human gliomas are classified using isocitrate dehydrogenase (IDH) status as a prognosticator; however, the influence of genetic differences and treatment effects on ensuing immunity remains unclear.